Research Summary
Analyzed using Evidence Intelligence™

Real-time glucose monitoring improves engagement in type 2 diabetes management

Last updated September 9, 2026

Key finding

Just halving my Hba1c, I’d never ever thought that would happen – ever.

This study explored the experiences of individuals with Type 2 Diabetes using real-time continuous glucose monitoring (rtCGM) while on insulin. Participants reported significant improvements in glycaemia and overall well-being.

Quick read

Study at a glance

The essential study design details in one scan.

EvidenceScore™

Moderate

Study type

RCTs

Follow-up

Medium-Term (3–12 mo)

Risk of bias

Some Concerns

Save research, organize studies, and quickly find important evidence again.

Plain-language summary

What this paper says

A plain-language read of the study’s main message and where it applies.

Study focus

This study explored the experiences of individuals with Type 2 Diabetes using real-time continuous glucose monitoring (rtCGM) while on insulin. Participants reported significant improvements in glycaemia and overall well-being.

Clinical relevance

This study highlights the potential benefits of rtCGM technology for individuals managing Type 2 Diabetes with insulin. Improved glycaemia and quality of life can lead to better long-term health outcomes, making rtCGM a valuable tool for diabetes management.

Keep in mind

The study had a single-arm design, limiting comparisons. Effectiveness data were unclear for several outcomes. Potential biases in self-reported data may affect reliability.

Published in

Journal Reference

Publication details and source links for this paper.

Oscar TS, Benjamin JW, Sara ES, et al. Exploring the Lived Experiences of Initiating Real-Time Continuous Glucose Monitoring Use in Individuals with Type 2 Diabetes Using Insulin. Journal of Diabetes and Metabolic Disorders. 2024;23(1):1163-1171. doi:10.1007/s40200-024-01403-9

Main Effects

Participants experienced a decrease in Hba1c by 15 mmol/mol, indicating improved glycaemia.

The frequency of glucose monitoring increased to 90%, showing greater engagement with diabetes management.

Adherence to insulin medication improved, with participants using their pens more reactively.

Evidence network

How this study fits

Understand where this research contributes within the broader evidence network.

Evidence Context

This study contributes evidence to Continuous glucose monitoring and Barriers to continual usage of rtCGM technology, Improved adherence to medication, Improved glycaemia, and 3 more.

Primary intervention

Continuous glucose monitoring

Primary outcomes

  • Barriers to continual usage of rtCGM technology
  • Improved adherence to medication
  • Improved glycaemia

Evidence relationships

Intervention and outcome relationships this study adds to the evidence network.

6
Evidence pairs
6
Relationships
1
Evidence topics
contributes_evidence

Editorial context

Why this study matters

See why this paper is useful beyond its individual results.

Evidence network role

This section describes how the study fits into the current evidence network. It does not determine whether an intervention works on its own.

Moderate contributionModerate confidenceNetwork score: 51

1

Related topics

6

Evidence pairs

244

Related studies

Why it is useful

  • Contributes to 6 evidence relationships
  • Includes primary outcome data
  • Linked to 0 direct semantic evidence topics

Topic contributions

Evidence topic

Contributes evidence

Add related evidence to your Evidence Tracker

Save studies and evidence pages, organize your personal Evidence Tracker, and keep the research you care about in one place.

Primary evidence

Evidence topic

Diabetes Technology

matched_intervention

Core evidence

Study findings

The primary outcomes reported in this study.

Barriers to continual usage of rtCGM technology

Continuous glucose monitoring → Barriers to continual usage of rtCGM technology

Continuous glucose monitoring → Barriers to continual usage of rtCGM technology

Evidence Intelligence™
EvidenceScore™
Emerging
Score 59 · Based on 1 study
ImpactScore™
50
Neutral
ConsistencyScore™
unclear
Not enough independent studies
Supporting studies: Based on 1 study
Add to Evidence Tracker

Improved adherence to medication

Continuous glucose monitoring → Improved adherence to medication

Continuous glucose monitoring → Improved adherence to medication

Evidence Intelligence™
EvidenceScore™
Emerging
Score 59 · Based on 1 study
ImpactScore™
100
Very Positive
ConsistencyScore™
unclear
Not enough independent studies
Supporting studies: Based on 1 study
Add to Evidence Tracker

Improved glycaemia

Continuous glucose monitoring → Improved glycaemia

Continuous glucose monitoring → Improved glycaemia

Evidence Intelligence™
EvidenceScore™
Emerging
Score 59 · Based on 1 study
ImpactScore™
100
Very Positive
ConsistencyScore™
unclear
Not enough independent studies
Supporting studies: Based on 1 study
Add to Evidence Tracker

Improved mood

Continuous glucose monitoring → Improved mood

Continuous glucose monitoring → Improved mood

Evidence Intelligence™
EvidenceScore™
Emerging
Score 59 · Based on 1 study
ImpactScore™
100
Very Positive
ConsistencyScore™
unclear
Not enough independent studies
Supporting studies: Based on 1 study
Add to Evidence Tracker

Improved sleep

Continuous glucose monitoring → Improved sleep

Continuous glucose monitoring → Improved sleep

Evidence Intelligence™
EvidenceScore™
Emerging
Score 59 · Based on 1 study
ImpactScore™
100
Very Positive
ConsistencyScore™
unclear
Not enough independent studies
Supporting studies: Based on 1 study
Add to Evidence Tracker

Increased frequency of monitoring

Continuous glucose monitoring → Increased frequency of monitoring

Continuous glucose monitoring → Increased frequency of monitoring

Evidence Intelligence™
EvidenceScore™
Emerging
Score 59 · Based on 1 study
ImpactScore™
100
Very Positive
ConsistencyScore™
unclear
Not enough independent studies
Supporting studies: Based on 1 study
Add to Evidence Tracker

Evidence Library

Build your evidence library

Save research, organize studies, and quickly find important evidence again.

evidence suggest

Evidence Suggest

  • Hba1c levels decreased by 15 mmol/mol, indicating better blood sugar control.
  • Participants reported a 90% increase in glucose monitoring frequency.
  • Medication adherence improved, with participants using insulin pens more reactively.
who this applies

Who this applies to

  • Adults with Type 2 Diabetes who are insulin-dependent.
  • Individuals seeking to improve their diabetes management through technology.
keep in mind

Keep in Mind

  • The study's findings may not be generalizable beyond the enrolled population.
  • Participants reported barriers to continuous use of rtCGM technology.
  • Effectiveness of the intervention remains unclear for some outcomes.
between the lines

Between the Lines

  • The study had a single-arm design, limiting comparisons.
  • Effectiveness data were unclear for several outcomes.
  • Potential biases in self-reported data may affect reliability.

Evidence Library

Build your evidence library

Save research, organize studies, and quickly find important evidence again.

Connected Evidence

Explore related studies, evidence collections, and research questions.

Relationships organized using the Dediabetes Evidence Intelligence™ framework.

This study contributes to evidence on Insulin Delivery Systems and Barriers to continual usage of rtCGM technology, Insulin Delivery Systems and Improved adherence to medication.

Related evidence relationships

Explore in Evidence Explorer

This study contributes to the evidence on the following intervention-outcome relationships.

Questions answered by this study

Generated from the study's connected evidence using Evidence Intelligence™.

Does Continuous glucose monitoring improve improved adherence to medication?

Emerging Evidence

Continuous glucose monitoring appears to improve improved adherence to medication.

ConsistencyScore™: Consistency cannot yet be determined from the available evidence.

Ranked evidence signals

  1. 1

    Improved adherence to medication

    EvidenceScore™ Emerging | EvidenceScore™ 59.0 | strong positive | ConsistencyScore™ Unclear | 1 study

Why this answer: This answer is based on a single supporting study.

Limitations

  • Only one supporting study is available.
1 supporting study

Does Continuous glucose monitoring improve improved glycaemia?

Emerging Evidence

Continuous glucose monitoring appears to improve improved glycaemia.

ConsistencyScore™: Consistency cannot yet be determined from the available evidence.

Ranked evidence signals

  1. 1

    Improved glycaemia

    EvidenceScore™ Emerging | EvidenceScore™ 59.0 | strong positive | ConsistencyScore™ Unclear | 1 study

Why this answer: This answer is based on a single supporting study.

Limitations

  • Only one supporting study is available.
1 supporting study

Does Continuous glucose monitoring improve improved mood?

Emerging Evidence

Continuous glucose monitoring appears to improve improved mood.

ConsistencyScore™: Consistency cannot yet be determined from the available evidence.

Ranked evidence signals

  1. 1

    Improved mood

    EvidenceScore™ Emerging | EvidenceScore™ 59.0 | strong positive | ConsistencyScore™ Unclear | 1 study

Why this answer: This answer is based on a single supporting study.

Limitations

  • Only one supporting study is available.
1 supporting study

Does Continuous glucose monitoring improve improved sleep?

Emerging Evidence

Continuous glucose monitoring appears to improve improved sleep.

ConsistencyScore™: Consistency cannot yet be determined from the available evidence.

Ranked evidence signals

  1. 1

    Improved sleep

    EvidenceScore™ Emerging | EvidenceScore™ 59.0 | strong positive | ConsistencyScore™ Unclear | 1 study

Why this answer: This answer is based on a single supporting study.

Limitations

  • Only one supporting study is available.
1 supporting study
Learn how Evidence Intelligence™ works

Next steps

Continue your research

Choose a next path through related evidence topics, Evidence Explorer views, and research summaries.

No ads. No tracking.

Focused on evidence, not advertising.

Secure & private

Your data is always protected.

Always up to date

New studies added every day.